The Adiponectin/Leptin Ratio and Metabolic Syndrome in Healthy Korean Adult Males

Corresponding author: Seung-Hyun Ko Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea, 93 Chi-dong, Paldal-gu, Suwon 442-723, Korea E-mail: [email protected] Insulin resistance plays an important role in the pathogenesis of obesity, metabolic syndrome and type 2 diabetes mellitus. Therefore, quantitative measurements of insulin resistance are clinically meaningful and may help researchers to better understand the etiologies of this disease. The best-established methods of quantitative measurement of insulin resistance are the hyperinsulinemic-euglycemic clamp, minimal model assessment and homeostatic model assessment (HOMA) methods [1]. However, given the dominant role of obesity in the pathogenesis of insulin resistance, plasma leptin and adiponectin levels, and the ratio of these two best-characterized adipocytokines, have been suggested as parameters to assess insulin resistance [2]. Several recent studies have shown that the leptin:adiponectin ratio (LAR) or the adiponectin/leptin (A/L) ratio is as strongly associated with the gold standard measure of insulin resistance (hyperinsulinemic-euglycemic clamp) as other currently used parameters such as fasting insulin or HOMA level. Leptin and adiponectin levels were measured in 2,097 non-diabetic individuals in the Ely and European Group for the Study of Insulin Resistance (EGIR) Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study cohorts. This was a large prospective, observational cohort study that involved healthy men and women aged between 30 and 60 years. According to this cohort study, the LAR was significantly correlated with HOMAS and the insulin sensitivity index drawn from the hyperinsulinemic–euglycemic clamp, both in men and women [2]. Moreover, some have reported that the LAR is a more effective parameter of insulin resistance than adiponectin, leptin alone, or HOMA-IR in non-diabetic and type 2 diabetes patients [3-5]. The present study measured adiponectin, leptin, and A/L ratio in 68 healthy adult Korean males. Although HOMA-IR is better correlated with percent body fat, triglyceride, and fasting glucose than A/L ratio, the results of this study demonstrated a significantly negative correlation between HOMA-IR and A/L ratio. Interestingly, the A/L ratio was significantly higher in patients with metabolic syndrome compared with its counterpart. A/L ratio decreased as the number of metabolic syndrome components increased. This finding corresponds to the results of a study by Zhuo et al. that included 2,046 older Chinese subjects (950 males, 220 with metabolic syndrome and 1,096 females, 452 with metabolic syndrome), aged 60-96 years. Zhuo et al. suggested that L/A ratio and leptin may be better diagnostic markers for metabolic syndrome than adiponectin level [6-8]. Moreover, there is some evidence that the L/A ratio is an independent predictor of carotid intima-media thickness [9-11]. Therefore, the A/L ratio may be a good candidate for predicting future atherosclerosis or metabolic syndrome, and eventually cardiovascular disease, in high risk subjects. Regarding the results of the present study, I would like to extend my appreciation for the efforts of the investigators, who have provided valuable evidence regarding the relationship beEditorial